Hydroxychloroquine and Risk of Long <scp>QT</scp> Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study With <scp>Nineteen‐Year</scp> Follow‐up-Reference-Cited by-同舟云学术

Hydroxychloroquine and Risk of Long QT Syndrome in Rheumatoid Arthritis: A Veterans Cohort Study With Nineteen‐Year Follow‐up

Published:2023-01-31 Issue: Volume: Page:
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Quiñones Mercedes E.¹,Joseph Joyce K.²,Dowell Sharon¹,Moore Hans J.³,Karasik Pamela E.⁴,Fonarow Gregg C.⁵,Fletcher Ross D.²,Cheng Yan⁶,Zeng‐Treitler Qing⁶,Arundel Cherinne⁷,Liappis Angelike P.⁷,Sheriff Helen M.⁶,Zhang Sijian²,Taub Daniel D.⁶,Heimall Michael S.²,Faselis Charles⁷,Kerr Gail S.⁸,Ahmed Ali⁹^ORCID

Affiliation:

1. Veterans Affairs Medical Center, and Howard University Washington DC

2. Veterans Affairs Medical Center Washington DC

3. Veterans Affairs Medical Center, Georgetown University, George Washington University, Uniformed Services University, and US Department of Veterans Affairs Washington DC

4. Veterans Affairs Medical Center, Georgetown University, George Washington University, and Uniformed Services University Washington DC

5. University of California Los Angeles CA

6. Veterans Affairs Medical Center and George Washington University Washington DC

7. Veterans Affairs Medical Center, George Washington University, and Uniformed Services University Washington DC

8. Veterans Affairs Medical Center, Howard University, and Georgetown University Washington DC

9. Veterans Affairs Medical Center, Georgetown University, and George Washington University Washington DC

Funder

U.S. Department of Veterans Affairs

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.25005

Reference42 articles.

1. Plaquenil® hydroxychloroquine sulfate tablets, USP;The Food and Drug Administration (FDA);Full prescribing information.,2021

2. Considerations for Drug Interactions on QTc Interval in Exploratory COVID-19 Treatment

3. QTc-interval prolongation and increased risk of sudden cardiac death associated with hydroxychloroquine

4. World Health Organization (WHO) Malaria Policy Advisory Committee.The cardiotoxicity of antimalarials.2017. URL:https://www.who.int/publications/m/item/meeting‐report‐of‐the‐evidence‐review‐group‐on‐the‐cardiotoxicity‐of‐antimalarials.

5. American College of Cardiology.Ventricular arrhythmia risk due to hydroxychloroquine‐azithromycin treatment for COVID‐19.2020. URL:https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating corrected QT prolongation with hydroxychloroquine use among patients with cutaneous sarcoidosis: A multicenter retrospective study;Journal of the American Academy of Dermatology;2024-06

2. Hydroxychloroquine and Chloroquine-Induced Cardiac Arrhythmias and Sudden Cardiac Death in Patients with Systemic Autoimmune Rheumatic Diseases: A Systematic Review and Meta-Analysis;Journal of Cardiovascular Pharmacology;2024-05-08

3. Long QT syndrome after using EGFR-TKIs in older patients with advanced non-small cell lung cancer;Expert Opinion on Drug Safety;2023-12-13

4. Association of Hydroxychloroquine Use with a Dose-Dependent Decrease in Mortality Risk in Patients with Elderly-Onset Rheumatoid Arthritis;Rheumatology and Therapy;2023-05-12